AmySClarkMD

Oncology • Philadelphia, PA

Physician

Join to view full profile

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Clark's full profile

Already have an account?

Office
3400 Civic Center Blvd
Dept Of
Philadelphia, PA 19104
Phone+1 215-615-5858

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2009 - 2012
Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
Pennsylvania State University College of MedicineClass of 2006

Certifications & Licensure

PA State Medical License 2009 - 2024
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) Start of enrollment: 2014 Jan 24
Completed
Phase 1

Publications & Presentations

PubMed

A Quantitative Bias Analysis Approach to Informative Presence Bias in Electronic Health Records.
Hanxi Zhang, Amy S Clark, Rebecca A Hubbard
Epidemiology. 2024-05-01
4 citations
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang
Clinical Cancer Research. 2024-02-16
1 citations
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Filipa Lynce, Laura E Stevens, Zheqi Li, Jane E Brock, Anushree Gulvady
Breast Cancer Research. 2024-01-31

Journal Articles

Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
Austin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research

Press Mentions

Combination Therapies Linked to Better Outcomes for Subset of Patients with Breast CancerJune 22nd, 2022
Breast Cancer Tx May Be Effective for Other Cancers, Study FindsDecember 31st, 2015
Palbociclib Breast Cancer Drug May Be Effective Against Other Types of CancerDecember 30th, 2015
Join now to see all